{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:51:11Z","timestamp":1789764671607,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jgar.2020.12.009","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T11:28:50Z","timestamp":1609586930000},"page":"98-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus"],"prefix":"10.1016","volume":"24","author":[{"given":"Hideo","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2020.12.009_bib0005","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","volume":"29","author":"Hidron","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2020.12.009_bib0010","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3201\/eid1312.070629","article-title":"Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005","volume":"13","author":"Klein","year":"2007","journal-title":"Emerg Infec Dis."},{"key":"10.1016\/j.jgar.2020.12.009_bib0015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.1995.03530080055041","article-title":"The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee","volume":"274","author":"Vincent","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2020.12.009_bib0020","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1097\/CCM.0b013e3181eb3b96","article-title":"Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis","volume":"38","author":"Kalil","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jgar.2020.12.009_bib0025","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1378\/chest.10-1556","article-title":"Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials","volume":"139","author":"Walkey","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jgar.2020.12.009_bib0030","article-title":"Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis","volume":"14","author":"Kalil","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jgar.2020.12.009_bib0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00228-014-1775-x","article-title":"Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis","volume":"71","author":"Wang","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jgar.2020.12.009_bib0040","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.12.009_bib0045","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jse.2013.01.017","article-title":"An assessment of the quality of rotator cuff randomized controlled trials: utilizing the Jadad score and CONSORT criteria","volume":"22","author":"McCormick","year":"2013","journal-title":"J Shoulder Elbow Surg"},{"key":"10.1016\/j.jgar.2020.12.009_bib0050","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration\u2019s tool for assessing risk of bias in randomized trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jgar.2020.12.009_bib0055","unstructured":"Wells GA, Shea B, Paterson J. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses, http:\/\/www.ohri.ca\/programs\/clinicalepidemiology\/oxford.asp; 2000 [accessed 01.12.2019]."},{"key":"10.1016\/j.jgar.2020.12.009_bib0060","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/340353","article-title":"Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"34","author":"Stevens","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.12.009_bib0065","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0012-3692(15)33412-7","article-title":"Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia","volume":"124","author":"Wunderink","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jgar.2020.12.009_bib0070","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jac\/dkm369","article-title":"Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan","volume":"60","author":"Kohno","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.12.009_bib0075","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1378\/chest.08-0011","article-title":"Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus","volume":"134","author":"Wunderink","year":"2008","journal-title":"Chest"},{"issue":"Suppl 4","key":"10.1016\/j.jgar.2020.12.009_bib0080","first-page":"439","article-title":"P1536: Linezolid versus vancomycin in the treatment of healthcare-associated pneumonia caused by culture-proven methicillin-resistant Staphylococcus aureus","volume":"17","author":"Bassetti","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2020.12.009_bib0085","first-page":"A3931","article-title":"Linezolid vs. vancomycin for ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus","volume":"183","author":"Shorr","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jgar.2020.12.009_bib0090","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/cir895","article-title":"Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study","volume":"54","author":"Wunderink","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.12.009_bib0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1378\/chest.07-1825","article-title":"The modified APACHE II score outperforms Curb65 pneumonia severity score as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus pneumonia","volume":"133","author":"Kollef","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jgar.2020.12.009_bib0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/0885066610392893","article-title":"Clinical outcomes of linezolid vs vancomycin in methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia: retrospective analysis","volume":"26","author":"Chan","year":"2011","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jgar.2020.12.009_bib0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.amjsurg.2012.10.011","article-title":"Improved outcome of ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in a trauma population","volume":"205","author":"Gonzalez","year":"2013","journal-title":"Am J Surg"},{"key":"10.1016\/j.jgar.2020.12.009_bib0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/phar.1390","article-title":"Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia","volume":"34","author":"Caffrey","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jgar.2020.12.009_bib0115","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1186\/cc13914","article-title":"Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study","volume":"18","author":"Peyrani","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.jgar.2020.12.009_bib0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.ccm.0000474279.47542.a0","article-title":"The effect of vancomycin and linezolid on the treatment and outcomes of presumed MRSA pneumonia","volume":"43","author":"Kinney","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jgar.2020.12.009_bib0125","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/phar.1771","article-title":"Comparison of linezolid and vancomycin for methicillin-resistant Staphylococcus aureus pneumonia: institutional implications","volume":"36","author":"Tong","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jgar.2020.12.009_bib0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ajem.2016.10.058","article-title":"Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: a retrospective cohort analysis: effectiveness of linezolid in the elderly","volume":"35","author":"Takada","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jgar.2020.12.009_bib0135","first-page":"3974","article-title":"Linezolid vs. vancomycin in treatment of methicillin-resistant Staphylococcus aureus infections: a meta-analysis","volume":"21","author":"Li","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jgar.2020.12.009_bib0140","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/phar.1771","article-title":"Comparison of linezolid and vancomycin for methicillin-resistant Staphylococcus aureus pneumonia: institutional implications","volume":"36","author":"Tong","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jgar.2020.12.009_bib0145","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.clinthera.2014.06.029","article-title":"Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid","volume":"36","author":"Niederman","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.jgar.2020.12.009_bib0150","first-page":"Doc02","article-title":"Treatment of MRSA pneumonia: clinical and economic comparison of linezolid vs. vancomycin \u2013 a retrospective analysis of medical charts and reimbursement data of real-life patient populations","volume":"5","author":"Wilke","year":"2017","journal-title":"GMS Infect Dis"},{"key":"10.1016\/j.jgar.2020.12.009_bib0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1473-3099(07)70312-2","article-title":"Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomized controlled trials","volume":"8","author":"Falagas","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2020.12.009_bib0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijantimicag.2009.09.013","article-title":"Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomized controlled trials","volume":"35","author":"Bibei","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2020.12.009_bib0165","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1128\/AAC.46.8.2723-2726.2002","article-title":"Hematologic effects of linezolid: summary of clinical experience","volume":"46","author":"Gerson","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2020.12.009_bib0170","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1086\/379327","article-title":"Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use","volume":"37","author":"Nasraway","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2020.12.009_bib0175","first-page":"379","article-title":"Vancomycin nephrotoxicity: myths and facts","volume":"69","author":"Gupta","year":"2011","journal-title":"Neth J Med"},{"key":"10.1016\/j.jgar.2020.12.009_bib0180","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/jac\/38.5.865","article-title":"Penetration of vancomycin into human lung tissue","volume":"38","author":"Cruciani","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2020.12.009_bib0185","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/510396","article-title":"Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus","volume":"195","author":"Stevens","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2020.12.009_bib0190","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","article-title":"Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection","volume":"290","author":"Naimi","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jgar.2020.12.009_bib0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3889\/oamjms.2019.009","article-title":"Vancomycin MIC distribution among methicillin-resistant Staphylococcus aureus. Is reduced vancomycin susceptibility related to MIC creep?","volume":"7","author":"Othman","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.jgar.2020.12.009_bib0200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cmi.2017.06.017","article-title":"Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections\u2013a systematic review and meta-analysis","volume":"24","author":"Diaz","year":"2018","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520303234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716520303234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:57:19Z","timestamp":1761991039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716520303234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":40,"alternative-id":["S2213716520303234"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2020.12.009","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2020.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}